Although both sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) ...

GLP-1RAs were linked to fewer asthma exacerbations and emergency visits in teens with obesity, suggesting potential ...

Even higher use seen in patients without type 2 diabetes. (HealthDay News) — The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) before surgery rose 16-fold among patients undergoing ...

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also ...

More than one-quarter of adults aged 25 to 64 years from 99 countries are eligible to receive a GLP-1 receptor agonist.

GLP-1 usage is on the rise, and researchers are looking for other health benefits associated with the drug, including its effects on bladder health. But as GLP-1s rise in popularity, so do nicknames ...

GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity or overweight with a related health condition. Read on for everything you need to know about GLP-1s for weight loss, ...

Media mogul Oprah Winfrey is poised to change how we talk about the GLP-1 trend. It's part of the 'Oprah Effect' on wellness.